Deep-tech neuroscience startup BrainSightAI secures $5 million in pre-Series A round led by IAN Alpha Fund
Bengaluru-based deep-tech neuroscience startup BrainSightAI has secured $5 million in its pre-Series A funding led by IAN Alpha Fund, according to a company statement. In the latest round, IvyCap Ventures, Silver Needle, and existing investors also participated.
The funding will help launch a milestone in BrainSightAI’s mission to revolutionize the diagnosis and treatment of complex brain disorders through its innovative neuroinformatics platform, VoxelBox, it said in a statement.
The funds will also be used to expand BrainSightAI’s presence in India, expanding its reach in Tier 1 cities and expanding to Tier 2 cities. The company also plans to pursue FDA certification, opening access to the US and allied markets.
Commenting on the investment, Priyank Garg, managing partner at IAN Alpha Fund said, “BrainSightAI’s mission to democratize access to personalized brain care is inspiring, and the technology they have created is a fundamental change in brain physiology. The connectivity platform, VoxelBox, has the potential to revolutionize the way mental disorders are diagnosed and treated for all of humanity At IAN, we are delighted to support this process as a purpose-driven company that integrates deep intelligence and impactful health care solutions.”
Founded in 2019 by Laina Emmanuel and Rimjhim Agrawal, BrainSightAI says it has partnered with more than 40 leading hospitals across India, particularly in the departments of neurosurgery and radiology, specializing in brain tumor cases.
IAN Alpha Fund, a Rs 1,000 crore (US$125 million) SEBI-registered AIF Category II VC Fund, is the second fund in the IAN Fund series. The fund will explore opportunities in various sectors such as fintech, healthtech, cleantech, AI, deep tech, agritech, medtech, hardware and electronics, production, Web 3.0, Metaverse, Industry 4.0, SaaS, D2C, and other areas where innovation is expanding.
